158 related articles for article (PubMed ID: 12029145)
1. Efficient mobilization of E1-deleted adenovirus type 5 vectors by wild-type adenoviruses of other serotypes.
Rademaker HJ; El Hassan MAA; Versteeg GA; Rabelink MJWE; Hoeben RC
J Gen Virol; 2002 Jun; 83(Pt 6):1311-1314. PubMed ID: 12029145
[TBL] [Abstract][Full Text] [Related]
2. Molecular characterization of replication-competent variants of adenovirus vectors and genome modifications to prevent their occurrence.
Hehir KM; Armentano D; Cardoza LM; Choquette TL; Berthelette PB; White GA; Couture LA; Everton MB; Keegan J; Martin JM; Pratt DA; Smith MP; Smith AE; Wadsworth SC
J Virol; 1996 Dec; 70(12):8459-67. PubMed ID: 8970968
[TBL] [Abstract][Full Text] [Related]
3. Improved adenovirus packaging cell lines to support the growth of replication-defective gene-delivery vectors.
Amalfitano A; Begy CR; Chamberlain JS
Proc Natl Acad Sci U S A; 1996 Apr; 93(8):3352-6. PubMed ID: 8622940
[TBL] [Abstract][Full Text] [Related]
4. Protease-deleted adenovirus vectors and complementing cell lines: potential applications of single-round replication mutants for vaccination and gene therapy.
Oualikene W; Lamoureux L; Weber JM; Massie B
Hum Gene Ther; 2000 Jun; 11(9):1341-53. PubMed ID: 10890743
[TBL] [Abstract][Full Text] [Related]
5. Novel complementation cell lines derived from human lung carcinoma A549 cells support the growth of E1-deleted adenovirus vectors.
Imler JL; Chartier C; Dreyer D; Dieterle A; Sainte-Marie M; Faure T; Pavirani A; Mehtali M
Gene Ther; 1996 Jan; 3(1):75-84. PubMed ID: 8929914
[TBL] [Abstract][Full Text] [Related]
6. Characterization of human adenovirus 35 and derivation of complex vectors.
McVey D; Zuber M; Ettyreddy D; Reiter CD; Brough DE; Nabel GJ; King CR; Gall JG
Virol J; 2010 Oct; 7():276. PubMed ID: 20959004
[TBL] [Abstract][Full Text] [Related]
7. A new type of adenovirus vector that utilizes homologous recombination to achieve tumor-specific replication.
Bernt K; Liang M; Ye X; Ni S; Li ZY; Ye SL; Hu F; Lieber A
J Virol; 2002 Nov; 76(21):10994-1002. PubMed ID: 12368342
[TBL] [Abstract][Full Text] [Related]
8. Characterization of 911: a new helper cell line for the titration and propagation of early region 1-deleted adenoviral vectors.
Fallaux FJ; Kranenburg O; Cramer SJ; Houweling A; Van Ormondt H; Hoeben RC; Van Der Eb AJ
Hum Gene Ther; 1996 Jan; 7(2):215-22. PubMed ID: 8788172
[TBL] [Abstract][Full Text] [Related]
9. Development of oncolytic and gene therapy vectors based on adenovirus serotype 4 as an alternative to adenovirus serotype 5.
Sallard E; Schulte L; van den Boom A; Klimovitskii A; Knierer J; Hagedorn C; Knocks M; Zhang W; Kreppel F; Ehrhardt A; Ehrke-Schulz E
J Gene Med; 2024 Jan; 26(1):e3576. PubMed ID: 37580111
[TBL] [Abstract][Full Text] [Related]
10. Human adenovirus type 35: nucleotide sequence and vector development.
Gao W; Robbins PD; Gambotto A
Gene Ther; 2003 Nov; 10(23):1941-9. PubMed ID: 14528318
[TBL] [Abstract][Full Text] [Related]
11. Replication of an adenoviral vector controlled by the human telomerase reverse transcriptase promoter causes tumor-selective tumor lysis.
Lanson NA; Friedlander PL; Schwarzenberger P; Kolls JK; Wang G
Cancer Res; 2003 Nov; 63(22):7936-41. PubMed ID: 14633724
[TBL] [Abstract][Full Text] [Related]
12. New helper cells and matched early region 1-deleted adenovirus vectors prevent generation of replication-competent adenoviruses.
Fallaux FJ; Bout A; van der Velde I; van den Wollenberg DJ; Hehir KM; Keegan J; Auger C; Cramer SJ; van Ormondt H; van der Eb AJ; Valerio D; Hoeben RC
Hum Gene Ther; 1998 Sep; 9(13):1909-17. PubMed ID: 9741429
[TBL] [Abstract][Full Text] [Related]
13. An adenovirus type 5 (Ad5) amplicon-based packaging cell line for production of high-capacity helper-independent deltaE1-E2-E3-E4 Ad5 vectors.
Catalucci D; Sporeno E; Cirillo A; Ciliberto G; Nicosia A; Colloca S
J Virol; 2005 May; 79(10):6400-9. PubMed ID: 15858023
[TBL] [Abstract][Full Text] [Related]
14. Development of cell lines capable of complementing E1, E4, and protein IX defective adenovirus type 5 mutants.
Krougliak V; Graham FL
Hum Gene Ther; 1995 Dec; 6(12):1575-86. PubMed ID: 8664382
[TBL] [Abstract][Full Text] [Related]
15. E1B functions of type C adenoviruses play a role in the complementation of blocked adenovirus type 12 DNA replication and late gene transcription in hamster cells.
Klimkait T; Doerfler W
Virology; 1987 Nov; 161(1):109-20. PubMed ID: 3672927
[TBL] [Abstract][Full Text] [Related]
16. A gene transfer vector-cell line system for complete functional complementation of adenovirus early regions E1 and E4.
Brough DE; Lizonova A; Hsu C; Kulesa VA; Kovesdi I
J Virol; 1996 Sep; 70(9):6497-501. PubMed ID: 8709289
[TBL] [Abstract][Full Text] [Related]
17. Recombinant adenoviruses with large deletions generated by Cre-mediated excision exhibit different biological properties compared with first-generation vectors in vitro and in vivo.
Lieber A; He CY; Kirillova I; Kay MA
J Virol; 1996 Dec; 70(12):8944-60. PubMed ID: 8971024
[TBL] [Abstract][Full Text] [Related]
18. Induction of endogenous genes following infection of human endothelial cells with an E1(-) E4(+) adenovirus gene transfer vector.
Ramalingam R; Rafii S; Worgall S; Hackett NR; Crystal RG
J Virol; 1999 Dec; 73(12):10183-90. PubMed ID: 10559334
[TBL] [Abstract][Full Text] [Related]
19. A recombinant E1-deleted porcine adenovirus-3 as an expression vector.
Zakhartchouk A; Zhou Y; Tikoo SK
Virology; 2003 Sep; 313(2):377-86. PubMed ID: 12954206
[TBL] [Abstract][Full Text] [Related]
20. A helper-independent adenovirus vector with E1, E3, and fiber deleted: structure and infectivity of fiberless particles.
Von Seggern DJ; Chiu CY; Fleck SK; Stewart PL; Nemerow GR
J Virol; 1999 Feb; 73(2):1601-8. PubMed ID: 9882366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
